News

Press Release | May 22, 2025

ImCheck Reports High Remission Rates in AML Patients with ICT01 Combination Therapy at ASCO 2025

News | March 13, 2025

Metagenomi Announces Publication in Nature Communications on Large Gene Integration Advances Using Novel, Compact CRISPR-associated transposase (CAST) Systems

Press Release | January 10, 2025

Primrose Bio to Collaborate with Serum Institute of India to Develop a Novel Multi-Antigen Vaccine

News | January 10, 2025

Lilly ventures into pulmonary fibrosis with startup Mediar

Press Release | January 10, 2025

Palvella Therapeutics Announces Publication of Results from Phase 2 Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Microcystic Lymphatic Malformations in the Journal of Vascular Anomalies

1 2